PMH21 COST-EFFECTIVENESS OF OLANZAPINE LONG-ACTING INJECTION IN THE TREATMENT OF NON-ADHERENCE PATIENTS WITH SCHIZOPHRENIA IN THE UNITED STATES
Ascher-Svanum, H, Furiak, NM, Klein, RW, Montgomery, W, Smolen, LJ, Lawson, AH, Conley, RR
Published in Value in health (2009)
Published in Value in health (2009)
Get full text
Journal Article
PMH38 ADHERENCE LEVELS AND DIFFERENTIAL USE OF MENTAL HEALTH SERVICES IN THE TREATMENT OF SCHIZOPHRENIA
Thomas, NA, Zhu, B, Ascher-Svanum, H, Faries, D, Montgomery, W, Furiak, NM
Published in Value in health (01.05.2006)
Published in Value in health (01.05.2006)
Get full text
Journal Article